Literature DB >> 26822809

A novel role for the deubiquitinase USP1 in the control of centrosome duplication.

Jin Ki Jung1, Seok-Won Jang1, Jung Min Kim1.   

Abstract

Defects in the regulation of centrosome duplication lead to tumorigenesis through abnormal cell division and resulting chromosome missegregation. Therefore, maintenance of accurate centrosome number is critical for cell fate. The deubiquitinating enzyme USP1 plays important roles in DNA repair and cell differentiation. Importantly, increased levels of USP1 are detected in certain types of human cancer, but little is known about the significance of USP1 overexpression in cancer development. Here we show that Usp1 plays a novel role in regulating centrosome duplication. The ectopic expression of wild-type Usp1, but not C90S Usp1 (catalytically inactive mutant form), induced centrosome amplification. Conversely, ablation of Usp1 in mouse embryonic fibroblasts (MEFs) showed a significant delay in centrosome duplication. Moreover, Usp1-induced centrosome amplification caused abnormal mitotic spindles, chromosome missegregation and aneuploidy. Interestingly, loss of inhibitor of DNA binding protein 1 (ID1) suppressed Usp1-induced centrosome amplification. Taken together, our results strongly suggest that Usp1 is involved in the regulation of centrosome duplication, at least in part via ID1, and Usp1 may exert its oncogenic activity, partially through inducing centrosome abnormality.

Entities:  

Keywords:  Aneuploidy; Centrosome amplification; Chromosome instability; Deubiquitinating Enzymes; Usp1

Mesh:

Substances:

Year:  2016        PMID: 26822809      PMCID: PMC5056607          DOI: 10.1080/15384101.2016.1138185

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

Review 1.  Centrosome composition and microtubule anchoring mechanisms.

Authors:  Michel Bornens
Journal:  Curr Opin Cell Biol       Date:  2002-02       Impact factor: 8.382

2.  The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.

Authors:  Sebastian M B Nijman; Tony T Huang; Annette M G Dirac; Thijn R Brummelkamp; Ron M Kerkhoven; Alan D D'Andrea; René Bernards
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

3.  Centrosome abnormalities in pancreatic ductal carcinoma.

Authors:  N Sato; K Mizumoto; M Nakamura; K Nakamura; M Kusumoto; H Niiyama; T Ogawa; M Tanaka
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

4.  Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.

Authors:  Jung Min Kim; Kalindi Parmar; Min Huang; David M Weinstock; Carrie Ann Ruit; Jeffrey L Kutok; Alan D D'Andrea
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

5.  USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.

Authors:  Ji Li; Vincenzo D'Angiolella; E Scott Seeley; Sehyun Kim; Tetsuo Kobayashi; Wenxiang Fu; Eric I Campos; Michele Pagano; Brian David Dynlacht
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

6.  The helix-loop-helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers.

Authors:  Jens Hasskarl; Stefan Duensing; Edwin Manuel; Karl Münger
Journal:  Oncogene       Date:  2004-03-11       Impact factor: 9.867

7.  USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis.

Authors:  Ying Zhang; Oded Foreman; Dennis A Wigle; Farhad Kosari; George Vasmatzis; Jeffrey L Salisbury; Jan van Deursen; Paul J Galardy
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

Review 8.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

Review 9.  USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy.

Authors:  Iraia García-Santisteban; Godefridus J Peters; Elisa Giovannetti; Jose Antonio Rodríguez
Journal:  Mol Cancer       Date:  2013-08-10       Impact factor: 27.401

Review 10.  Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer.

Authors:  German A Pihan
Journal:  Front Oncol       Date:  2013-11-12       Impact factor: 6.244

View more
  6 in total

1.  The X-linked deubiquitinase USP9X is an integral component of centrosome.

Authors:  Qian Wang; Yiman Tang; Yue Xu; Shilei Xu; Yong Jiang; Qiuping Dong; Yongsheng Zhou; Wenshu Ge
Journal:  J Biol Chem       Date:  2017-06-15       Impact factor: 5.157

2.  UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression.

Authors:  Hui Song; Chunyuan Zhao; Zhongxia Yu; Qizhao Li; Rongzhen Yan; Ying Qin; Mutian Jia; Wei Zhao
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

3.  USP9X regulates centrosome duplication and promotes breast carcinogenesis.

Authors:  Xin Li; Nan Song; Ling Liu; Xinhua Liu; Xiang Ding; Xin Song; Shangda Yang; Lin Shan; Xing Zhou; Dongxue Su; Yue Wang; Qi Zhang; Cheng Cao; Shuai Ma; Na Yu; Fuquan Yang; Yan Wang; Zhi Yao; Yongfeng Shang; Lei Shi
Journal:  Nat Commun       Date:  2017-03-31       Impact factor: 14.919

4.  ATAD5 suppresses centrosome over-duplication by regulating UAF1 and ID1.

Authors:  Seong-Jung Kim; Minwoo Wie; Su Hyung Park; Tae Moon Kim; Jun Hong Park; Shinseog Kim; Kyungjae Myung; Kyoo-Young Lee
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

Review 5.  Regulation of the cell cycle and centrosome biology by deubiquitylases.

Authors:  Sarah Darling; Andrew B Fielding; Dorota Sabat-Pośpiech; Ian A Prior; Judy M Coulson
Journal:  Biochem Soc Trans       Date:  2017-09-12       Impact factor: 5.407

Review 6.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.